5T4 oncofetal antigen expression in ovarian carcinoma.

PubWeight™: 1.09‹?› | Rank: Top 10%

🔗 View Article (PMID 11578488)

Published in Int J Gynecol Cancer on July 01, 1995

Authors

E. Wrigley1, A.T. McGown, J. Rennison, R. Swindell, D. Crowther, T. Starzynska, P.L. Stern

Author Affiliations

1: CRC Department of Medical Oncology, Christie Hospital, CRC Department of Experimental Chemotherapy, Paterson Institute, CRC Department of Medical Statistics, Christie Hospital, CRC Department of Immunology, Paterson Institute, Manchester, UK.

Articles citing this

CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer. PLoS One (2006) 1.68

E-cadherin inhibits cell surface localization of the pro-migratory 5T4 oncofetal antigen in mouse embryonic stem cells. Mol Biol Cell (2007) 1.26

Phase II trial of Modified Vaccinia Ankara (MVA) virus expressing 5T4 and high dose Interleukin-2 (IL-2) in patients with metastatic renal cell carcinoma. J Transl Med (2009) 1.03

Role of the epithelial-mesenchymal transition and its effects on embryonic stem cells. Exp Mol Med (2014) 0.96

Characterization of the murine 5T4 oncofoetal antigen: a target for immunotherapy in cancer. Biochem J (2002) 0.88

CXCR4 mediated chemotaxis is regulated by 5T4 oncofetal glycoprotein in mouse embryonic cells. PLoS One (2010) 0.86

Development of modified vaccinia Ankara-5T4 as specific immunotherapy for advanced human cancer. Expert Opin Biol Ther (2008) 0.86

Identification of a major histocompatibility complex class I-restricted T-cell epitope in the tumour-associated antigen, 5T4. Immunology (2006) 0.83

A Novel Strategy for Detection and Enumeration of Circulating Rare Cell Populations in Metastatic Cancer Patients Using Automated Microfluidic Filtration and Multiplex Immunoassay. PLoS One (2015) 0.81

Naptumomab estafenatox: targeted immunotherapy with a novel immunotoxin. Curr Oncol Rep (2014) 0.79

Glycosylation and epitope mapping of the 5T4 glycoprotein oncofoetal antigen. Biochem J (2002) 0.79

Identification of Pre- and Post-Treatment Markers, Clinical, and Laboratory Parameters Associated with Outcome in Renal Cancer Patients Treated with MVA-5T4. Front Oncol (2013) 0.78

First-in-human trial of an anti-5T4 antibody-monomethylauristatin conjugate, PF-06263507, in patients with advanced solid tumors. Invest New Drugs (2017) 0.76

Marine Antibody-Drug Conjugates: Design Strategies and Research Progress. Mar Drugs (2017) 0.75

5T4-targeted therapy ablates cancer stem cells and prevents recurrence of head and neck squamous cell carcinoma. Clin Cancer Res (2016) 0.75

Detecting expression of 5T4 in CTCs and tumor samples from NSCLC patients. PLoS One (2017) 0.75

Articles by these authors

Carcinosarcoma of the ovary treated over a 10-year period at the Christie Hospital. Int J Gynecol Cancer (1994) 0.90